Research Reports

  • 14 September 2017

    Emerging rivals in CAR-T cell therapies

    The recent acquisition deal by Gilead for Kite Pharma has meant a huge opportunity for the biopharmaceutical to provide an opportunity for novel cancer immunotherapies.

  • 8 August 2017

    Novartis leads Japanese clinical trials

    As part of our series of white papers tracking clinical trials activity across the world, GlobalData recently compiled a summary of the clinical trials initiated in Japan.


Go Top